These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 36928856)

  • 1. The Role of fMRI in Drug Development: An Update.
    Carmichael O
    Adv Neurobiol; 2023; 30():299-333. PubMed ID: 36928856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fMRI in drug discovery.
    Wise RG; Tracey I
    J Magn Reson Imaging; 2006 Jun; 23(6):862-76. PubMed ID: 16649197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption.
    Nathan PJ; Bakker G
    Psychopharmacology (Berl); 2021 May; 238(5):1255-1263. PubMed ID: 31900526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the value of human FMRI in CNS drug development?
    Wise RG; Preston C
    Drug Discov Today; 2010 Nov; 15(21-22):973-80. PubMed ID: 20813202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for fMRI in optimizing CNS drug development.
    Borsook D; Becerra L; Hargreaves R
    Nat Rev Drug Discov; 2006 May; 5(5):411-24. PubMed ID: 16604100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning to identify CNS drug action and efficacy using multistudy fMRI data.
    Duff EP; Vennart W; Wise RG; Howard MA; Harris RE; Lee M; Wartolowska K; Wanigasekera V; Wilson FJ; Whitlock M; Tracey I; Woolrich MW; Smith SM
    Sci Transl Med; 2015 Feb; 7(274):274ra16. PubMed ID: 25673761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fMRI in drug development.
    Carmichael O; Schwarz AJ; Chatham CH; Scott D; Turner JA; Upadhyay J; Coimbra A; Goodman JA; Baumgartner R; English BA; Apolzan JW; Shankapal P; Hawkins KR
    Drug Discov Today; 2018 Feb; 23(2):333-348. PubMed ID: 29154758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of imaging in proof of concept for CNS drug discovery and development.
    Wong DF; Tauscher J; Gründer G
    Neuropsychopharmacology; 2009 Jan; 34(1):187-203. PubMed ID: 18843264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New acquisition techniques and their prospects for the achievable resolution of fMRI.
    Bollmann S; Barth M
    Prog Neurobiol; 2021 Dec; 207():101936. PubMed ID: 33130229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of functional imaging across clinical phases in CNS drug development.
    Borsook D; Becerra L; Fava M
    Transl Psychiatry; 2013 Jul; 3(7):e282. PubMed ID: 23860483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological FMRI in the development of new analgesic compounds.
    Schweinhardt P; Bountra C; Tracey I
    NMR Biomed; 2006 Oct; 19(6):702-11. PubMed ID: 16986120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of structural and functional magnetic resonance imaging improves mild cognitive impairment detection.
    Kim J; Lee JH
    Magn Reson Imaging; 2013 Jun; 31(5):718-32. PubMed ID: 23260395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological MRI (phMRI) of the Human Central Nervous System.
    Lanfermann H; Schindler C; Jordan J; Krug N; Raab P
    Clin Neuroradiol; 2015 Oct; 25 Suppl 2():259-66. PubMed ID: 26329611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift in translational neuroimaging of CNS disorders.
    Sakoğlu U; Upadhyay J; Chin CL; Chandran P; Baker SJ; Cole TB; Fox GB; Day M; Luo F
    Biochem Pharmacol; 2011 Jun; 81(12):1374-87. PubMed ID: 21219879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a magnetic resonance-compatible dentoalveolar tactile stimulus device.
    Moana-Filho EJ; Nixdorf DR; Bereiter DA; John MT; Harel N
    BMC Neurosci; 2010 Oct; 11():142. PubMed ID: 21029454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining EEG and fMRI.
    Mullinger K; Bowtell R
    Methods Mol Biol; 2011; 711():303-26. PubMed ID: 21279609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional neuronavigation combined with intra-operative 3D ultrasound: initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data.
    Rasmussen IA; Lindseth F; Rygh OM; Berntsen EM; Selbekk T; Xu J; Nagelhus Hernes TA; Harg E; Håberg A; Unsgaard G
    Acta Neurochir (Wien); 2007; 149(4):365-78. PubMed ID: 17308976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.
    Klumpers LE; Cole DM; Khalili-Mahani N; Soeter RP; Te Beek ET; Rombouts SA; van Gerven JM
    Neuroimage; 2012 Nov; 63(3):1701-11. PubMed ID: 22885247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application and Progress of Real-time Interleaved Transcranial Magnetic Stimulation Functional Magnetic Resonance Imaging].
    Ma YQ; Xie RX; Zheng Z; Ma D; Wu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):592-598. PubMed ID: 32975070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards motion insensitive EEG-fMRI: Correcting motion-induced voltages and gradient artefact instability in EEG using an fMRI prospective motion correction (PMC) system.
    Maziero D; Velasco TR; Hunt N; Payne E; Lemieux L; Salmon CEG; Carmichael DW
    Neuroimage; 2016 Sep; 138():13-27. PubMed ID: 27157789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.